Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice.
O'Donnell, R T
Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. [electronic resource] - The Prostate Aug 2000 - 187-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0270-4137
10.1002/1097-0045(20000801)44:3<187::aid-pros2>3.0.co;2-c doi
Animals
Antibodies, Monoclonal--therapeutic use
Body Weight
Dose-Response Relationship, Radiation
Female
Heterocyclic Compounds--blood
Humans
Leukocyte Count
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Oligopeptides--blood
Platelet Count
Prostatic Neoplasms--radiotherapy
Radioimmunotherapy--adverse effects
Radiopharmaceuticals--blood
Specific Pathogen-Free Organisms
Tumor Cells, Cultured
Whole-Body Counting
Yttrium--blood
Yttrium Radioisotopes--blood
Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. [electronic resource] - The Prostate Aug 2000 - 187-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0270-4137
10.1002/1097-0045(20000801)44:3<187::aid-pros2>3.0.co;2-c doi
Animals
Antibodies, Monoclonal--therapeutic use
Body Weight
Dose-Response Relationship, Radiation
Female
Heterocyclic Compounds--blood
Humans
Leukocyte Count
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Oligopeptides--blood
Platelet Count
Prostatic Neoplasms--radiotherapy
Radioimmunotherapy--adverse effects
Radiopharmaceuticals--blood
Specific Pathogen-Free Organisms
Tumor Cells, Cultured
Whole-Body Counting
Yttrium--blood
Yttrium Radioisotopes--blood